Plasma disposition of capecitabine (CCB) and its metabolites 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouracil (5'-DFUR) with two different capecitabine/oxaliplatin dosage regimens.
作者信息
Farkouh A, Schueller J, Scheithauer W, Czejka M
机构信息
Department of Clinical Pharmacy and Diagnostics, University of Vienna, Vienna, Austria.
出版信息
Int J Clin Pharmacol Ther. 2010 Jul;48(7):487-8. doi: 10.5414/cpp48487.
DOI:10.5414/cpp48487
PMID:20557855
Abstract
摘要
Zotero 插件